Romano Kelly A

Average Profitability
<0.0001%
Insider Buys Quantity
4
Insider Buys Sum
$303,630.72
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Romano Kelly A

According to the SEC Form 4 filings, Romano Kelly A, being in a position of

  1. director at Athira Pharma, Inc.,
    оver the last 12 months, has bought 42400 shares for $100,051, and sold 0 shares,
    over all time since 2022-03-31, has bought 80400 shares for $303,631, and sold 0 shares.

The largest purchase of all time was on 2022-03-31 and amounted to 8000 shares of Athira Pharma, Inc. for $104,880.

Biography of Romano Kelly A

No biography is available at this moment.

2024-06-24PurchaseAthira Pharma, Inc.
ATHA
director
27,400
0.0729%
$2.42$66,179-75.36%
2024-06-21PurchaseAthira Pharma, Inc.
ATHA
director
15,000
0.0347%
$2.26$33,872-74.11%
2022-12-02PurchaseAthira Pharma, Inc.
ATHA
director
30,000
0.0797%
$3.29$98,700-14.63%
2022-03-31PurchaseAthira Pharma, Inc.
ATHA
8,000
0.0206%
$13.11$104,880-74.96%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.